| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
,
Departments of
*
Microbiology and
Internal Medicine, University of Iowa, and
VA Medical Center, Iowa City, IA 52242
In B lymphocytes, CD40 signals contribute to the activation of Ab secretion, isotype switching, T cell costimulation, and immunological memory. TRAF proteins appear to be important components of the CD40 signal transduction complex, but their roles in the activation of B cell effector functions are poorly understood. We examined the contributions of TNF receptor-associated factor 2 (TRAF2) and TRAF3 to CD40-activated differentiation in mouse B cells transfected with inducible TRAF and dominant-negative TRAF cDNAs. We find that binding of TRAF2 and TRAF3 to CD40 is not required for the induction of Ab secretion, but that both TRAF molecules can regulate the activation process. We demonstrate a negative regulatory role for TRAF3 and that this activity is dependent on the availability of an intact TRAF3-binding site in the cytoplasmic domain of CD40. In contrast, TRAF2 appears to play a positive role in B cell differentiation, and this activity is apparent even when its binding site on CD40 is disrupted.
This article has been cited by other articles:
|
|
 |
|
  H. H. Jabara, Y. Weng, T. Sannikova, and R. S. Geha TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40 Int. Immunol., April 1, 2009; 21(4): 477 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Rowland, M. M. Tremblay, J. M. Ellison, L. L. Stunz, G. A. Bishop, and B. S. Hostager A Novel Mechanism for TNFR-Associated Factor 6-Dependent CD40 Signaling J. Immunol., October 1, 2007; 179(7): 4645 - 4653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Vonderheide Prospect of Targeting the CD40 Pathway for Cancer Therapy Clin. Cancer Res., February 15, 2007; 13(4): 1083 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Xie, B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling J. Immunol., May 1, 2006; 176(9): 5388 - 5400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Andrade, M. Wessendarp, J.-A. C. Portillo, J.-Q. Yang, F. J. Gomez, J. E. Durbin, G. A. Bishop, and C. S. Subauste TNF Receptor-Associated Factor 6-Dependent CD40 Signaling Primes Macrophages to Acquire Antimicrobial Activity in Response to TNF-{alpha} J. Immunol., November 1, 2005; 175(9): 6014 - 6021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wu, P. Xie, K. Welsh, C. Li, C.-Z. Ni, X. Zhu, J. C. Reed, A. C. Satterthwait, G. A. Bishop, and K. R. Ely LMP1 Protein from the Epstein-Barr Virus Is a Structural CD40 Decoy in B Lymphocytes for Binding to TRAF3 J. Biol. Chem., September 30, 2005; 280(39): 33620 - 33626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Moore and G. A. Bishop Differential Regulation of CD40-Mediated TNF Receptor-Associated Factor Degradation in B Lymphocytes J. Immunol., September 15, 2005; 175(6): 3780 - 3789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hauer, S. Puschner, P. Ramakrishnan, U. Simon, M. Bongers, C. Federle, and H. Engelmann TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-{kappa}B pathway by TRAF-binding TNFRs PNAS, February 22, 2005; 102(8): 2874 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Munroe and G. A. Bishop Role of Tumor Necrosis Factor (TNF) Receptor-associated Factor 2 (TRAF2) in Distinct and Overlapping CD40 and TNF Receptor 2/CD120b-mediated B Lymphocyte Activation J. Biol. Chem., December 17, 2004; 279(51): 53222 - 53231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Xie, B. S. Hostager, and G. A. Bishop Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes J. Exp. Med., March 1, 2004; 199(5): 661 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Haxhinasto and G. A. Bishop Synergistic B Cell Activation by CD40 and the B Cell Antigen Receptor: ROLE OF B LYMPHOCYTE ANTIGEN RECEPTOR-MEDIATED KINASE ACTIVATION AND TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTOR REGULATION J. Biol. Chem., January 23, 2004; 279(4): 2575 - 2582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Clatza, L. C. Bonifaz, D. A. A. Vignali, and J. Moreno CD40-Induced Aggregation of MHC Class II and CD80 on the Cell Surface Leads to an Early Enhancement in Antigen Presentation J. Immunol., December 15, 2003; 171(12): 6478 - 6487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Hostager, S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling J. Biol. Chem., November 14, 2003; 278(46): 45382 - 45390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-F. Lu, W. J. Cook, L.-L. Lin, and R. J. Noelle CD40 Signaling through a Newly Identified Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2) Binding Site J. Biol. Chem., November 14, 2003; 278(46): 45414 - 45418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Haxhinasto and G. A. Bishop A Novel Interaction between Protein Kinase D and TNF Receptor-Associated Factor Molecules Regulates B Cell Receptor-CD40 Synergy J. Immunol., November 1, 2003; 171(9): 4655 - 4662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. SM. Rahman, S. P. Rao, S. L. Kalled, and T. Manser Normal Induction but Attenuated Progression of Germinal Center Responses in BAFF and BAFF-R Signaling-Deficient Mice J. Exp. Med., October 20, 2003; 198(8): 1157 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C M Gelbmann, S N Leeb, D Vogl, M Maendel, H Herfarth, J Scholmerich, W Falk, and G Rogler Inducible CD40 expression mediates NF{kappa}B activation and cytokine secretion in human colonic fibroblasts Gut, October 1, 2003; 52(10): 1448 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Propst, K. Estell, and L. M. Schwiebert CD40-mediated Activation of NF-kappa B in Airway Epithelial Cells J. Biol. Chem., September 27, 2002; 277(40): 37054 - 37063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Haxhinasto, B. S. Hostager, and G. A. Bishop Cutting Edge: Molecular Mechanisms of Synergy Between CD40 and the B Cell Antigen Receptor: Role for TNF Receptor-Associated Factor 2 in Receptor Interaction J. Immunol., August 1, 2002; 169(3): 1145 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Qian, Z. Zhao, Z. Jiang, and X. Li Role of NFkappa B activator Act1 in CD40-mediated signaling in epithelial cells PNAS, July 9, 2002; 99(14): 9386 - 9391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Bishop, B. S. Hostager, and K. D. Brown Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes J. Leukoc. Biol., July 1, 2002; 72(1): 19 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Brown, B. S. Hostager, and G. A. Bishop Regulation of TRAF2 Signaling by Self-induced Degradation J. Biol. Chem., May 24, 2002; 277(22): 19433 - 19438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Hostager and G. A. Bishop Role of TNF Receptor-Associated Factor 2 in the Activation of IgM Secretion by CD40 and CD120b J. Immunol., April 1, 2002; 168(7): 3318 - 3322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Busch and G. A. Bishop Multiple Carboxyl-Terminal Regions of the EBV Oncoprotein, Latent Membrane Protein 1, Cooperatively Regulate Signaling to B Lymphocytes Via TNF Receptor-Associated Factor (TRAF)-Dependent and TRAF-Independent Mechanisms J. Immunol., November 15, 2001; 167(10): 5805 - 5813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Brown, B. S. Hostager, and G. A. Bishop Differential Signaling and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Degradation Mediated by CD40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (LMP1) J. Exp. Med., April 16, 2001; 193(8): 943 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. H. Lee, S. E. Lee, K. Kwack, W. Yeo, T. H. Lee, S. S. Bae, P.-G. Suh, and H.-H. Kim Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells J. Leukoc. Biol., March 1, 2001; 69(3): 490 - 496. [Abstract] [Full Text]
|
|
|
|
|
|
G. A. Bishop, Y. Hsing, B. S. Hostager, S. V. Jalukar, L. M. Ramirez, and M. A. Tomai Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848 J. Immunol., November 15, 2000; 165(10): 5552 - 5557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Z. Ni, K. Welsh, E. Leo, C.-k. Chiou, H. Wu, J. C. Reed, and K. R. Ely Molecular basis for CD40 signaling mediated by TRAF3 PNAS, September 12, 2000; 97(19): 10395 - 10399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cerutti, A. Schaffer, R. G. Goodwin, S. Shah, H. Zan, S. Ely, and P. Casali Engagement of CD153 (CD30 Ligand) by CD30+ T Cells Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD+ IgM+ B Cells J. Immunol., July 15, 2000; 165(2): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bhushan, B. Barnhart, S. Shone, C. Song, and L. R. Covey A Transcriptional Defect Underlies B Lymphocyte Dysfunction in a Patient Diagnosed with Non-X-Linked Hyper-IgM Syndrome J. Immunol., March 15, 2000; 164(6): 2871 - 2880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. V. Jalukar, B. S. Hostager, and G. A. Bishop Characterization of the Roles of TNF Receptor-Associated Factor 6 in CD40-Mediated B Lymphocyte Effector Functions J. Immunol., January 15, 2000; 164(2): 623 - 630. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
